This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Jonathan F Critchlow during the Masters Biliary: Help! Severe Acute Cholecystitis – How to Recognize, And What To Do! on April 14 2018
Keyword(s): acalculus, adverse events, antibiotics, AXIOS stent, BDI, bias, bile duct injury, blood cultures, calculus disease, cardiologist, CBD stent, chemotherapy, cholangiogram, cholecystostomy, chronic cholecystitis, Cochrane review, cohort, common bile duct stent, comorbidities, comorbidity, conversion, delayed surgery, disease severity, drive line, early cholecystectomy, elderly, emphysematous cholecystitis, endoscopic approach, endpoint, fibrosis, gallbladder, hardware, heart disease, high risk, inflammatory cholecystitis, laparoscopic cholecystectomy, left ventricular access device, low risk, LVAD, masters biliary, meta-analysis, metastatic pancreatic cancer, morbidity, nasobiliary drain, pathological diagnosis, porta hepatis, propensity score analysis, pus, registry, resuscitation, sepsis, severe acute cholecystitis, stomach, Sweden, wound infection
Low risk patients–59 sec Br J Surg 2015
Propensity score analysis–6:02 Ann Surg 2014
Is 72 hrs the magic number?–7:20 Ann Surg 2016
High risk patients–10:07
Tx of acute cholecystitis–13:16